tiprankstipranks
Bright Minds Biosciences Inc. (DRUG)
:DRUG
US Market
Holding DRUG?
Track your performance easily

Bright Minds Biosciences Inc. (DRUG) Financial Statements

205 Followers

Bright Minds Biosciences Inc. Financial Overview

Bright Minds Biosciences Inc.'s market cap is currently ―. The company's EPS TTM is $-0.504; its P/E ratio is ―; Bright Minds Biosciences Inc. is scheduled to report earnings on March 11, 2025, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Sep 23Dec 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT--$ -2.26M$ -2.66M$ -4.48M
EBITDA--$ -2.24M$ -2.66M$ -4.48M
Net Income Common Stockholders--$ -2.34M$ -2.66M$ -4.49M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.72M$ 6.75M$ 11.21M$ 8.64M$ 11.47M
Total Assets$ 6.10M$ 6.88M$ 11.55M$ 8.82M$ 11.76M
Total Debt$ 118.96K$ ―$ 124.48K$ ―$ ―
Net Debt$ -5.60M$ ―$ -11.09M$ ―$ ―
Total Liabilities$ 568.26K$ 280.86K$ 582.66K$ 385.32K$ 1.00M
Stockholders Equity$ 5.54M$ 6.60M$ 10.97M$ 8.43M$ 10.76M
Cash Flow-
Free Cash Flow--$ -2.66M$ -2.86M$ -3.65M
Operating Cash Flow--$ -2.66M$ -2.86M$ -3.65M
Investing Cash Flow-----
Financing Cash Flow--$ 2.25M$ 12.00K$ 1.68K
Currency in USD

Bright Minds Biosciences Inc. Earnings and Revenue History

Bright Minds Biosciences Inc. Debt to Assets

Bright Minds Biosciences Inc. Cash Flow

Bright Minds Biosciences Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis